BioCentury
ARTICLE | Clinical News

Synthetic retrotransposon vectors regulatory update

September 17, 2001 7:00 AM UTC

Nature Technology received U.S. Patent No. 6,287,863 covering its VL30 retrotransposon vector for delivery and expression of transgenes. Nature Technology said the patent also covers the production of...